Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
35.89M
Cash
8.691M
Avg Qtr Burn
-3.947M
Short % of Float
4.51%
Insider Ownership
26.41%
Institutional Own.
5.29%
Qtr Updated
09/30/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
THIO Details Non-small cell lung carcinoma, Cancer | Phase 3 Initiation | |
THIO Details Non-small cell lung carcinoma, Cancer, Hepatocellular carcinoma, Small cell lung cancer, Colorectal cancer | Phase 2 Update |